• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

2006 Public Health Advisories

Update on Magnetic Resonance Imaging (MRI) Contrast Agents Containing Gadolinium and Nephrogenic Fibrosing Dermopathy (12/22/2006)

Life-threatening Brain Infection in Patients with Systemic Lupus Erythematosus After Rituxan (Rituximab) Treatment (12/18/2006)

Methadone Use for Pain Control May Result in Death and Life-Threatening Changes in Breathing and Heart Beat (11/27/2006)

Epoetin alfa (marketed as Procrit, Epogen) Darbepoetin alfa (marketed as Aranesp) (11/16/2006)

Aprotinin Injection (marketed as Trasylol) (9/29/2006)

Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns (7/19/2006)

Combined Use of 5-Hydroxytryptamine Receptor Agonists (Triptans), Selective Serotonin Reuptake Inhibitors (SSRIs) or Selective Serotonin/Norepinephrine Reuptake Inhibitors (SNRIs) May Result in Life-threatening Serotonin Syndrome. (7/19/2006)

Consumers Should Not Use Triaminic Vapor Patch (6/20/2006)

Gadolinium-containing Contrast Agents for Magnetic Resonance Imaging (MRI) (6/8/2006)

Angiotensin-Converting Enzyme Inhibitor (ACE inhibitor) Drugs and Pregnancy (6/7/2006)

Serevent Diskus (salmeterol xinafoate inhalation powder), Advair Diskus (fluticasone propionate & salmeterol inhalation powder), Foradil Aerolizer (formoterol fumarate inhalation powder) (5/15/2006)

Diastat AcuDial (3/30/2006)

Sepsis and medical abortion with mifepristone (Mifeprex) (3/17/2006)

Benzocaine Sprays marketed under different names, including Hurricaine, Topex, and Cetacaine (2/10/2006)

Trasylol (aprotinin injection) (2/8/2006)

Ketek (telithromycin) Tables (1/20/2006)

FDA warns of consequences of drug name confusion in U.S. prescriptions filled abroad.  FDA News  Public Health Advisory (1/11/2006)